Anti-HBs response in seroconverting chronic HBV carriers following alpha-interferon treatment
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 10 (3), 350-352
- https://doi.org/10.1016/0168-8278(90)90145-h
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.Gut, 1989
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988
- A Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States ArmyNew England Journal of Medicine, 1987
- Lymphoblastoid interferon therapy of chronic HBV infectionJournal of Hepatology, 1987
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver DiseaseSeminars in Liver Disease, 1986
- A Randomized Study of the Effects of Adenine Arabinoside 5′–Monophosphate (Short or Long Courses) and Lymphoblastoid Interferon on Hepatitis B Virus ReplicationHepatology, 1985
- Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.Journal of Clinical Investigation, 1983
- CELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEThe Lancet, 1972